Categories

Newsletter

ALIMTA 100mg (pemetrexed disodium)

ALIMTA 100mg (pemetrexed disodium)
Hover over image to zoom
Price: $390.00
Product ID : alimta_100mg
Manufacturer: ELI-LILLY
Shipping Price: $37.50
E-mail to a friend | Add To Wish List

Purchase

Min/Max Order: 1 / 12

Description

ALIMTA

Generic Name: pemetrexed disodium
Dosage Form: injection, powder

Patient Education - English

  • Generic Name: pemetrexed
  • Pronounced: pem e TREX ed
  • Brand Name: Alimta

What is the most important information I should know about pemetrexed?

 

Before receiving pemetrexed, tell your doctor if you are allergic to any drugs, or if you have kidney or liver disease, bone marrow suppression, a weak immune system, or excess fluid in the space around your lung, liver, or other internal organs.

Throughout your treatment with pemetrexed, you will need to take folic acid and vitamin B-12 to protect your stomach, blood cells, and bone marrow from the side effects of pemetrexed. You will need to start taking these supplements a week before receiving your first pemetrexed infusion, and will keep taking them for 3 weeks after your treatment ends.

Vitamin B-12 and folic acid are available over the counter. Be sure to take only the forms and strengths of these supplements that your doctor has recommended.

Pemetrexed is usually given every 3 weeks. Your doctor will determine how many treatment cycles you should receive.

Pemetrexed can lower the blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. To be sure your blood cells do not get too low, your blood will need to be tested on a regular basis. Your cancer treatments may be delayed based on the results of these tests. Do not miss any scheduled visits to your doctor.

Avoid being near people who have colds, the flu, or other contagious illnesses. Contact your doctor at once if you develop signs of infection.

Before you receive pemetrexed, tell your doctor if you are taking an NSAID (non-steroidal anti-inflammatory drug) such as ibuprofen (Motrin, Advil), naproxen (Aleve, Naprosyn), indomethacin (Indocin), ketoprofen (Orudis), and others.

What is pemetrexed?

Pemetrexed is a cancer medication that interferes with the growth of cancer cells and slows their growth and spread in the body.

Pemetrexed is used to treat mesothelioma, a form of lung cancer associated with exposure to asbestos. Pemetrexed is also used to treat non-small cell lung cancer that has already been treated with other cancer medications.

Pemetrexed may also be used for other purposes not listed in this medication guide.

What should I discuss with my healthcare provider before receiving pemetrexed?

 

You should not receive this medication if you are allergic to pemetrexed.

If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before you receive pemetrexed, tell your doctor if you are allergic to any drugs, or if you have:

  • kidney disease;
  • liver disease;
  • bone marrow suppression;
  • a weak immune system; or
  • excess fluid in the space around your lung, liver, or other internal organs, including pleural effusion (fluid around the lungs) or ascites (fluid around the liver).

FDA pregnancy category D. This medication can cause harm to an unborn baby. Do not receive pemetrexed without telling your doctor if you are pregnant. Use an effective form of birth control, and tell your doctor if you become pregnant during treatment.

It is not known whether pemetrexed passes into breast milk or if it could harm a nursing baby. Do not receive this medication without telling your doctor if you are breast-feeding a baby.

How is pemetrexed given?

 

Pemetrexed is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting. The medicine must be given slowly through an IV infusion, and can take up to 10 minutes to complete.

Throughout your treatment with pemetrexed, you will need to take folic acid and vitamin B-12 to protect your stomach, blood cells, and bone marrow from the side effects of pemetrexed. You will need to start taking these supplements a week before receiving your first pemetrexed infusion, and will keep taking them for 3 weeks after your treatment ends.

Vitamin B-12 and folic acid are available over the counter. Be sure to take only the forms and strengths of these supplements that your doctor has recommended.

Your doctor may also prescribe steroid medications to reduce certain side effects of pemetrexed.

To treat mesothelioma, the pemetrexed injection is usually followed by infusion of cisplatin (Platinol) 30 minutes later. Cisplatin must be given very slowly, and is usually infused over 2 hours.

Pemetrexed is usually given every 3 weeks. Your doctor will determine how many treatment cycles you should receive.

Pemetrexed can lower the blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. To be sure your blood cells do not get too low, your blood will need to be tested on a regular basis. Your cancer treatments may be delayed based on the results of these tests. Do not miss any scheduled visits to your doctor.

What happens if I miss a dose?

Contact your doctor if you miss an appointment to have your pemetrexed injection.

What happens if I overdose?

 

Seek emergency medical attention if you think you have received too much of this medicine.

Overdose may cause fever, chills, body aches, flu symptoms, mouth sores or white patches, and severe diarrhea.

What should I avoid while receiving pemetrexed?

Avoid being near people who have colds, the flu, or other contagious illnesses. Contact your doctor at once if you develop signs of infection.

What are the possible side effects of pemetrexed?

 

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have any of these serious side effects:

  • pale skin, easy bruising or bleeding, unusual weakness;
  • fever, chills, body aches, flu symptoms;
  • white patches or sores inside your mouth or on your lips;
  • urinating less than usual, or not at all;
  • chest pain, trouble breathing;
  • swelling, rapid weight gain.

Less serious side effects may include:

  • skin rash;
  • numbness or tingling;
  • depressed mood;
  • sore throat;
  • tired feeling;
  • nausea, vomiting, diarrhea, constipation, indigestion, loss of appetite; or
  • muscle pain.

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect pemetrexed?

Before receiving pemetrexed, tell your doctor if you are using any of the following drugs:

  • probenecid (Benemid);
  • an NSAID (non-steroidal anti-inflammatory drug) such as ibuprofen (Motrin, Advil), naproxen (Aleve, Naprosyn), diclofenac (Voltaren), diflunisal (Dolobid), etodolac (Lodine), flurbiprofen (Ansaid), indomethacin (Indocin), ketoprofen (Orudis), ketorolac (Toradol), mefenamic acid (Ponstel), meloxicam (Mobic), nabumetone (Relafen), piroxicam (Feldene), and others.

This list is not complete and there may be other drugs that can interact with pemetrexed. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

Where can I get more information?

Your pharmacist can provide more information about pemetrexed.


Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Pill Pictures

Alimta (pemetrexed) 100 mg
Alimta (pemetrexed) 100 mg
Alimta (pemetrexed) 500 mg
Alimta (pemetrexed) 500 mg


ALIMTA, a resource for patients with advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) or malignant pleural mesothelioma (MPM), and the people who care for them. Alimta is a cancer medication that interferes with the growth of cancer cells and slows their growth and spread in the body. Alimta is used to treat mesothelioma, a form of lung cancer associated with exposure to asbestos. Alimta is also used to treat non-small cell lung cancer that has already been treated with other cancer medications.

HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use Alimta safely and effectively. See full prescribing information for Alimta.
Alimta (pemetrexed disodium) Injection, Powder, Lyophilized, For Solution for Intravenous Use
Initial U.S. Approval: 2004


RECENT MAJOR CHANGES

Indications and Usage, Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer Combination with Cisplatin           09/2008

Indications and Usage, Locally Advanced or Metastatic Nonsquamous Non Small Cell Lung Cancer Maintenance           07/2009

Indications and Usage, Locally Advanced or Metastatic Nonsquamous Non Small Cell Lung Cancer After Prior Chemotherapy           09/2008

Dosage and Administration, Combination Use with Cisplatin           09/2008


Indications and Usage for Alimta

Alimta® is a folate analog metabolic inhibitor indicated for:

  • Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer:
    • Initial treatment in combination with cisplatin.
    • Maintenance treatment of patients whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.
    • After prior chemotherapy as a single-agent.
  • Mesothelioma: in combination with cisplatin.

Limitations of Use:

  • Alimta is not indicated for the treatment of patients with squamous cell non-small cell lung cancer.

Alimta Dosage and Administration

  • Combination use in Non-Small Cell Lung Cancer and Mesothelioma: Recommended dose of Alimta is 500 mg/m2 i.v. on Day 1 of each 21-day cycle in combination with cisplatin 75 mg/m2 i.v. beginning 30 minutes after Alimta administration.
  • Single-Agent use in Non-Small Cell Lung Cancer: Recommended dose of Alimta is 500 mg/m2 i.v. on Day 1 of each 21-day cycle.
  • Dose Reductions: Dose reductions or discontinuation may be needed based on toxicities from the preceding cycle of therapy.

 

Initial Diagnosis of Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer

ALIMTA (pemetrexed for injection) is approved by the FDA in combination with cisplatin (another chemotherapy drug) for the initial treatment of advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC. ALIMTA is not indicated for patients who have different type of NSCLC called squamous cell.

To Maintain the Effect of Initial Chemotherapy Before Worsening of Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer

ALIMTA as a single agent (used alone) is approved for maintaining the initial treatment effect of chemotherapy in patients with advanced nonsquamous non-small cell lung cancer whose disease has not worsened after initial therapy. ALIMTA is not indicated for patients who have another type of non-small cell lung cancer called squamous cell.

If Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer Returns

ALIMTA is approved by the FDA as a single agent (used alone) for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, after prior chemotherapy. ALIMTA is not indicated for patients who have a different type of NSCLC called squamous cell.

Treatment for Malignant Pleural Mesothelioma

ALIMTA is a treatment for malignant pleural mesothelioma (MPM), which is a cancer that affects the inside lining of the chest cavity. ALIMTA is given with cisplatin, another anticancer medicine (chemotherapy), when surgery is not an option.

Important Safety Information for ALIMTA (pemetrexed for injection)

ALIMTA is approved by the FDA in combination with cisplatin (another chemotherapy drug) for the initial treatment of advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC. ALIMTA is not indicated for patients who have a different type of NSCLC called squamous cell.

ALIMTA as a single agent (used alone) is approved for maintaining the initial treatment effect of chemotherapy in patients with advanced nonsquamous non-small cell lung cancer whose disease has not worsened after initial therapy. ALIMTA is not indicated for patients who have another type of non-small cell lung cancer called squamous cell.

ALIMTA is approved by the FDA as a single agent (used alone) for the treatment of patients with advanced nonsquamous non-small cell lung cancer (NSCLC), a specific type of NSCLC, after prior chemotherapy. ALIMTA is not indicated for patients who have a different type of NSCLC called squamous cell.

ALIMTA is a treatment for malignant pleural mesothelioma (MPM), which is a cancer that affects the inside lining of the chest cavity. ALIMTA is given with cisplatin, another anticancer medicine (chemotherapy), when surgery is not an option.

ALIMTA may not be appropriate for some patients. If you are allergic to ALIMTA, tell your doctor because you should not receive it. If you think you are pregnant, are planning to become pregnant, or are nursing, please tell your healthcare team. ALIMTA may harm your unborn or nursing baby. Your physician may advise you to use effective contraception (birth control) to prevent pregnancy while you are being treated with ALIMTA.

If you have liver or kidney problems, be sure to tell your doctor. Your dose of ALIMTA may have to be changed, or ALIMTA may not be right for you. There is a risk of side effects associated with ALIMTA therapy. ALIMTA can suppress bone marrow function. It is very important to take folic acid and vitamin B12 prior to and during your treatment with ALIMTA to lower your chances of harmful side effects.

Your healthcare professional will prescribe a medicine called a corticosteroid, which lowers your chances of getting skin reactions with ALIMTA. Ask your healthcare professional before taking medicines called NSAIDs (nonsteroidal anti-inflammatory drugs used to treat pain or swelling). Tell your doctor if you are taking other medicines, including prescription and non-prescription medicines, vitamins, and herbal supplements.

The most common side effects of ALIMTA when given alone or in combination with cisplatin, another chemotherapy drug, are low blood cell counts (red blood cells, white blood cells, and platelets); tiredness; stomach upset, including nausea, vomiting, and diarrhea; mouth, throat, or lip sores; loss of appetite; rash; and constipation.

Call your healthcare professional right away if you have a fever, chills, diarrhea, or mouth sores. These symptoms could mean you have an infection. These are not all of the side effects of ALIMTA. If you have any side effect that bothers you or that doesn't go away, be sure to talk with your healthcare professional.

You will have regular blood tests before and during your treatment with ALIMTA. Your doctor may adjust your dose of ALIMTA or delay your treatment based on the results of your blood test and on your general condition.

For more information about all of the side effects of ALIMTA, please talk with your healthcare team, see the Patient Prescribing Information.

HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use Alimta safely and effectively. See full prescribing information for Alimta.
Alimta (pemetrexed disodium) Injection, Powder, Lyophilized, For Solution for Intravenous Use
Initial U.S. Approval: 2004

Comment on Facebook

Product Reviews

Login or Register to write the first review.

Products You May Like